Healthcare IT
On Wednesday May 16 I will be presenting at the iMedicine & Mobile Life Sciences World Summit concerning smartphones as the next frontier in medical imaging, telemedicine and EMRs. I am presenting with Tobin Arthur of Cureus. Cureus is revolutionizing medical publishing and is founded by John Adler, a famous neurosurgeon at Stanford. Physicians today use […]
Read MoreI’m excited that we have recently added a new portfolio company Genalyte to the Claremont Creek digital healthcare family. I’ll be joining the Board, and I am looking forward to working with founder and CEO Cary Gunn and the Genalyte team. Genalyte is a developer and manufacturer of advanced biomarker detection technology strategically located right […]
Read More
March 7, 2012 source: Angel Capital Association (ACA) AssureRx Health, Inc. Receives 2012 ACA Luis Villalobos Award for Innovation Angel Capital Association Recognizes Company For Industry-leading Personalized Medicine Solution Hats off to one of my portfolio companies, AssureRx today received the the 2012 Luis Villalobos Award from the Angel Capital Association (ACA), the trade association of […]
Read More
January 18, 2012 source: MedCity News Personalized medicine company AssureRx Health has released the next-generation version of its genetic screening test for psychiatric drugs. The Cincinnati-area company’s GeneSightRx test, which helps doctors pick the right psychiatric drugs for patients based on their genes, was launched in 2009. The test uses a cheek swab, mathematical […]
Read More
September 9, 2011 source: originally published in the San Francisco Business Times Gene Security Network’s race to develop safer, more accurate prenatal test is all business for Matt Rabinowitz — and it’s personal. A relative of Rabinowitz, Gene Security Network’s CEO, took a blood test for the likelihood of Down’s syndrome in her unborn baby and […]
Read More
October 9, 2011 source: CBS News As part of CBS morning news, TIBION was profiled by correspondent Barry Peterson. At approximately four minutes 21 seconds into the video, see how TIBION stands out. We are proud of our portfolio company that is getting worldwide recognition. The next step in bionics … The new world of […]
Read MoreMeet our team
Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.
NAT GOLDHABER
Nat Goldhaber is a co-founder of Claremont Creek Ventures.
BRAD WEBB
Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.
RANDY HAWKS
Randy Hawks is a co-founder of Claremont Creek Ventures.